Close Menu
Home » NCI-MATCH Sees Lots of Enthusiasm in Initial Months; Not Many Matches

NCI-MATCH Sees Lots of Enthusiasm in Initial Months; Not Many Matches

Jan 22, 2016
|
Turna Ray
Premium

NEW YORK (GenomeWeb) – Enthusiasm for participating in the National Cancer Institute's MATCH trial has been higher than investigators expected, but, according to researchers knowledgeable of the project, the study hasn't yet "matched" many patients to treatments based on the genomic markers driving their disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Keep Them or Not?

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

Dunno Whose It Is

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

Knowing Risk From a Young Age

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

Science Translational Medicine Paper Finds Drug Combo Boosts KRAS Inhibitor Efficacy in Lung Cancer

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Sep
25
Featured Webinar

Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development

Sponsored by
HalioDx

CAR T-cell therapy is an innovative form of immunotherapy that is finding increasing use for the management of blood cancers. 

Oct
08
Featured Webinar

Integration of Single Cell and Spatially Resolved Methods for Understanding Neurodegeneration in ALS

Sponsored by
10x Genomics

This webinar will discuss a study that used spatial transcriptomics to gain insight into the molecular mechanisms of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease.

Oct
10
Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

Sponsored by
Roche

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
21
Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Sponsored by
Agilent

Genomics is a key element in the potential of precision medicine to transform oncology. 

What's Popular?

In Molecular Diagnostics

  1. Roche Gains FDA Clearance for Cobas Babesia Blood Test

  2. Germany's Publicly Funded Insurance to Cover NIPT Under Limited Circumstances

  3. HTG Molecular Diagnostics Prices $20M in Stock Offerings

  4. Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia

    Premium

  5. Bionano Genomics Commences Public Stock Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.